{
    "clinical_study": {
        "@rank": "43566", 
        "arm_group": [
            {
                "arm_group_label": "deep neuromuscular blockade", 
                "arm_group_type": "Active Comparator", 
                "description": "Deep neuromuscular blockade (PTC 0-1) with rocuronium 1 mg/kg followed by no neuromuscular blockade with sugammadex 8 mg/kg and placebo reversal.\nMeasurements of intraabdominal distance during deep neuromuscular blockade and without neuromuscular blockade"
            }, 
            {
                "arm_group_label": "no neuromuscular blockade", 
                "arm_group_type": "Placebo Comparator", 
                "description": "No neuromuscular blockade with placebo followed by deep neuromuscular blockade (PTC 0-1) with rocuronium 1 mg/kg and reversal with sugammadex 8 mg/kg.\nMeasurements of intraabdominal distance during no neuromuscular blockade and during deep neuromuscular blockade."
            }
        ], 
        "brief_summary": {
            "textblock": "To investigate if deep neuromuscular blockade improves intraabdominal volume compared to no\n      neuromuscular blockade in patients scheduled for gynecologic laparoscopic surgery with\n      pneumoperitoneum 12 mmHg.\n\n      Hypothesis:\n\n      Deep neuromuscular blockade improves intraabdominal space (the distance from promontorium to\n      skin surface, cm) compared to no neuromuscular blockade."
        }, 
        "brief_title": "Optimizing Surgical Conditions During Gynecologic Laparoscopic Surgery With Deep Neuromuscular Blockade", 
        "condition": "Neuromuscular Blockade", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients > 18 years old\n\n          -  elective laparoscopic operation\n\n          -  can read and understand Danish\n\n          -  informed consent\n\n        Exclusion Criteria:\n\n          -  BMI > 30 kg/cm2\n\n          -  known allergy to medications that are included in the project,\n\n          -  severe renal disease, defined by S-creatinine> 0,200 mmol/L, GFR < 30ml/min or\n             hemodialysis),\n\n          -  neuromuscular disease that may interfere with neuromuscular data,\n\n          -  lactating or pregnant,\n\n          -  impaired liver function,\n\n          -  converting to laparotomy,\n\n          -  perioperative use of neuromuscular blocking agents before randomization,\n\n          -  pneumoperitoneum set to >12 mmHg on the insufflator"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "14", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 28, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01933425", 
            "org_study_id": "NMBDK2013", 
            "secondary_id": "2013-001164-29"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "deep neuromuscular blockade", 
                    "no neuromuscular blockade"
                ], 
                "intervention_name": "rocuronium", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "deep neuromuscular blockade", 
                    "no neuromuscular blockade"
                ], 
                "intervention_name": "sugammadex", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "deep neuromuscular blockade", 
                    "no neuromuscular blockade"
                ], 
                "intervention_name": "placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Rocuronium"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "surgical conditions", 
            "laparoscopy"
        ], 
        "lastchanged_date": "January 16, 2014", 
        "location": {
            "contact": {
                "email": "olav.istre@aleris-hamlet.dk", 
                "last_name": "Olav Istre, professor", 
                "phone": "+45 21277472"
            }, 
            "facility": {
                "address": {
                    "city": "Copenhagen", 
                    "country": "Denmark", 
                    "state": "S\u00f8borg", 
                    "zip": "2830"
                }, 
                "name": "Department of minimal invasive gynecology Aleris-Hamlet Private Hospital"
            }, 
            "investigator": {
                "last_name": "Matias Vested Madsen, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "2", 
        "official_title": "Optimizing Surgical Conditions: Intraabdominal Distance During Gynecologic Laparoscopic Surgery With and Without Muscle Relaxation (The Measurement Study)", 
        "overall_contact": {
            "email": "matias.vested.madsen@regionh.dk", 
            "last_name": "Matias Vested Madsen, MD", 
            "phone": "+4538689058"
        }, 
        "overall_contact_backup": {
            "email": "mona.gatke@regionh.dk", 
            "last_name": "Mona G\u00e4tke, MD, ph.d", 
            "phone": "+4538682420"
        }, 
        "overall_official": [
            {
                "affiliation": "Department of Anesthesiology Herlev Hospital", 
                "last_name": "Matias Vested Madsen, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Department of minimal invasive gynecology, Aleris-Hamlet, Copenhagen", 
                "last_name": "Olav Istre, MD, DMSc, professor", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Denmark: Danish Health and Medicines Authority", 
                "Denmark: Ethics Committee"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Difference in intraabdominal distance from promontorium to the edge of the trocar in umbilicus at 12 mmHg with and without deep neuromuscular blockade (PTC 0-1).", 
            "measure": "Intraabdominal distance (centimeters)", 
            "safety_issue": "No", 
            "time_frame": "1 hour"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01933425"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Herlev Hospital", 
            "investigator_full_name": "Matias Vested Madsen", 
            "investigator_title": "research assistent, MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Difference in intraabdominal distance from promontorium to the edge of the trocar in umbilicus at 8 mmHg with and without deep neuromuscular blockade (PTC 0-1).", 
            "measure": "Intraabdominal distance (centimeters)", 
            "safety_issue": "No", 
            "time_frame": "1 hour"
        }, 
        "source": "Herlev Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Herlev Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}